Swiss pharmaceutical group Sandoz reported a slowdown in operational momentum, with adjusted metrics masking lackluster underlying performance in its latest financial update.
The company, a Novartis spin-off, highlighted adjusted figures as a key focus, though raw operational data failed to meet expectations. Analysts noted the divergence between adjusted and reported metrics, raising questions about the sustainability of Sandoz’s growth trajectory.
In contrast, Swiss real estate firm HIAG Immobilien AG projected a record profit for 2026, driven by strong demand in its core markets. The company’s outlook reflects robust leasing activity and stable occupancy rates across its portfolio, positioning it for outperformance in the sector.
Meanwhile, Chinese automaker Geely Automobile Holdings reported a recovery in its latest earnings, rebounding from prior-period declines. The company cited improved vehicle deliveries and cost efficiencies as key drivers of its turnaround, though macroeconomic headwinds in China’s automotive sector remain a risk factor.
The mixed performance across the trio underscores divergent trends in Swiss and Chinese markets, with HIAG’s optimism contrasting Sandoz’s challenges and Geely’s stabilization efforts.
